Veracyte (VCYT) News Today $30.13 +0.57 (+1.93%) Closing price 04/2/2025 04:00 PM EasternExtended Trading$27.00 -3.13 (-10.39%) As of 05:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Raymond James Financial Inc. Makes New $1.63 Million Investment in Veracyte, Inc. (NASDAQ:VCYT)Raymond James Financial Inc. acquired a new stake in Veracyte, Inc. (NASDAQ:VCYT - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 41,064 shares of the biotechnology company's stock, valued at approximatelyApril 3 at 3:06 AM | marketbeat.comVeracyte, Inc. (NASDAQ:VCYT) Shares Bought by Prudential Financial Inc.Prudential Financial Inc. grew its holdings in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 602.6% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 122,003 shares of the biotechnology company's stock after purchasing an additional 104,6April 2 at 3:57 AM | marketbeat.comCritical Review: Veracyte (NASDAQ:VCYT) vs. CannLabs (OTCMKTS:CANL)March 31 at 1:47 AM | americanbankingnews.comVeracyte, Inc. (NASDAQ:VCYT) Holdings Increased by IQ EQ FUND MANAGEMENT IRELAND LtdIQ EQ FUND MANAGEMENT IRELAND Ltd increased its stake in Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 90.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 18,156 shares of the biotechnology compaMarch 30, 2025 | marketbeat.comLoomis Sayles & Co. L P Takes $16.22 Million Position in Veracyte, Inc. (NASDAQ:VCYT)Loomis Sayles & Co. L P purchased a new position in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 409,702 shares of the biotechnology cMarch 30, 2025 | marketbeat.comSei Investments Co. Has $14.26 Million Stake in Veracyte, Inc. (NASDAQ:VCYT)Sei Investments Co. raised its stake in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 33.7% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 360,106 shares of the biotechnology company's stock after purchasing an additional 90,863 shaMarch 30, 2025 | marketbeat.comVeracyte (VCYT) Introduces AI-Powered Cancer Detection – Faster and More Accurate Than Ever!March 29, 2025 | msn.comArtisan Partners Limited Partnership Acquires 1,576,432 Shares of Veracyte, Inc. (NASDAQ:VCYT)Artisan Partners Limited Partnership increased its stake in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 31.4% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 6,599,264 shares of the biotechnology company's stock after buying an additional 1,576,4March 28, 2025 | marketbeat.comVeracyte (NASDAQ:VCYT) Shares Down 6.1% - Time to Sell?Veracyte (NASDAQ:VCYT) Shares Down 6.1% - Here's WhyMarch 27, 2025 | marketbeat.comVeracyte (NASDAQ:VCYT) Earns "Overweight" Rating from StephensStephens reiterated an "overweight" rating and set a $45.00 price objective on shares of Veracyte in a research report on Wednesday.March 27, 2025 | marketbeat.comVeracyte (VCYT) Shares Cross Above 200 DMAMarch 27, 2025 | nasdaq.comNew Data Demonstrate Accuracy of Veracyte’s Whole-Genome Sequencing-Based MRD Testing Platform for Muscle-Invasive Bladder CancerMarch 27, 2025 | finance.yahoo.comSegall Bryant & Hamill LLC Reduces Position in Veracyte, Inc. (NASDAQ:VCYT)Segall Bryant & Hamill LLC reduced its position in Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 2.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 433,874 shares of the biotechnology company's stock after selling 10March 27, 2025 | marketbeat.comTeacher Retirement System of Texas Buys 51,362 Shares of Veracyte, Inc. (NASDAQ:VCYT)Teacher Retirement System of Texas lifted its stake in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 329.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 66,974 shares of the biotechnology company's stockMarch 26, 2025 | marketbeat.comNew Data Demonstrate Accuracy of Veracyte's Whole-Genome Sequencing-Based MRD Testing Platform for Muscle-Invasive Bladder CancerMarch 25, 2025 | businesswire.comVeracyte, Inc. (NASDAQ:VCYT) Shares Sold by Advantage Alpha Capital Partners LPAdvantage Alpha Capital Partners LP cut its position in Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 31.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 17,129 shares of the biotechnology company's stock afMarch 25, 2025 | marketbeat.com11,821 Shares in Veracyte, Inc. (NASDAQ:VCYT) Purchased by Harvest Fund Management Co. LtdHarvest Fund Management Co. Ltd acquired a new position in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 11,821 shares of the biotechnology company's stock, valued at approximately $468,000. AMarch 23, 2025 | marketbeat.comVeracyte, Inc. (NASDAQ:VCYT) Shares Bought by Parallel Advisors LLCParallel Advisors LLC increased its stake in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 6,108.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,567 shares of the biotechnologMarch 23, 2025 | marketbeat.comVeracyte, Inc. (NASDAQ:VCYT) Stock Holdings Lowered by Corient Private Wealth LLCCorient Private Wealth LLC reduced its holdings in Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 8.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 121,245 shares of the biotechnology company's stoMarch 23, 2025 | marketbeat.comCraig Hallum Initiates Coverage on Veracyte (NASDAQ:VCYT)Craig Hallum began coverage on shares of Veracyte in a report on Thursday. They set a "buy" rating and a $45.00 price target for the company.March 21, 2025 | marketbeat.comVeracyte initiated with a Buy at Craig-HallumMarch 21, 2025 | markets.businessinsider.comCraig-Hallum bullish on Veracyte, initiates with a BuyMarch 21, 2025 | markets.businessinsider.com6VCYT : 5 Analysts Assess Veracyte: What You Need To KnowMarch 21, 2025 | benzinga.comCraig-Hallum Initiates Coverage of Veracyte (VCYT) with Buy RecommendationMarch 21, 2025 | msn.comAlphaQuest LLC Sells 8,728 Shares of Veracyte, Inc. (NASDAQ:VCYT)AlphaQuest LLC trimmed its stake in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 88.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,151 shares of the biotechnology company's stock afMarch 21, 2025 | marketbeat.comProficio Capital Partners LLC Acquires New Holdings in Veracyte, Inc. (NASDAQ:VCYT)Proficio Capital Partners LLC bought a new position in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 29,779 shares of the biotechnology company's sMarch 21, 2025 | marketbeat.comVeracyte Announces Eight Abstracts Highlighting Performance and Clinical Utility of Its Decipher and MRD Tests in Urologic Cancers To Be Presented at EAU25March 19, 2025 | businesswire.comNikko Asset Management Americas Inc. Reduces Stock Position in Veracyte, Inc. (NASDAQ:VCYT)Nikko Asset Management Americas Inc. lessened its stake in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 9.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,493,377 shares of thMarch 18, 2025 | marketbeat.comVictory Capital Management Inc. Cuts Stock Holdings in Veracyte, Inc. (NASDAQ:VCYT)Victory Capital Management Inc. decreased its position in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 33.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 56,538 shares of the biotechnologyMarch 18, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Sells 14,038 Shares of Veracyte, Inc. (NASDAQ:VCYT)Charles Schwab Investment Management Inc. trimmed its stake in Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 1.9% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 720,969 shares of the biotechnology company's stock after selliMarch 18, 2025 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Decreases Stake in Veracyte, Inc. (NASDAQ:VCYT)Connor Clark & Lunn Investment Management Ltd. decreased its position in Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 22.6% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 279,331 shares of the biotechnology company's stock after selling 81,5March 16, 2025 | marketbeat.comGreat Lakes Advisors LLC Has $3.57 Million Position in Veracyte, Inc. (NASDAQ:VCYT)Great Lakes Advisors LLC lowered its holdings in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 34.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 90,117 shares of the biotechnologyMarch 16, 2025 | marketbeat.comBank of New York Mellon Corp Purchases 20,906 Shares of Veracyte, Inc. (NASDAQ:VCYT)Bank of New York Mellon Corp boosted its position in Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 9.4% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 243,452 shares of the biotechnology company's stock after purchasing an aMarch 15, 2025 | marketbeat.comVeracyte, Inc. (NASDAQ:VCYT) Given Average Recommendation of "Moderate Buy" by AnalystsShares of Veracyte, Inc. (NASDAQ:VCYT - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the eight ratings firms that are presently covering the company, MarketBeat reports. One research analyst has rated the stock with a sell rating, one has issued a hold raMarch 15, 2025 | marketbeat.comVeracyte (VCYT) Surged on Reporting Strong EarningsMarch 10, 2025 | msn.comM&T Bank Corp Buys 10,121 Shares of Veracyte, Inc. (NASDAQ:VCYT)M&T Bank Corp boosted its stake in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 16.5% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 71,382 shares of the biotechnology company's stock after buying an additional 10,121 shares duringMarch 9, 2025 | marketbeat.com29,779 Shares in Veracyte, Inc. (NASDAQ:VCYT) Purchased by Proficio Capital Partners LLCProficio Capital Partners LLC acquired a new stake in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 29,779 shares of the biotechnology compaMarch 8, 2025 | marketbeat.comVestmark Advisory Solutions Inc. Increases Holdings in Veracyte, Inc. (NASDAQ:VCYT)Vestmark Advisory Solutions Inc. increased its stake in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 12.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 137,367 shares of the biotechnologyMarch 7, 2025 | marketbeat.comInsider Sell: Phillip Febbo Sells Shares of Veracyte Inc (VCYT)March 6, 2025 | gurufocus.comVeracyte Full Year 2024 Earnings: EPS Misses ExpectationsMarch 4, 2025 | finance.yahoo.comVeracyte (VCYT) Gets a Buy from ScotiabankMarch 4, 2025 | markets.businessinsider.comVeracyte's (NASDAQ:VCYT) Performance Is Even Better Than Its Earnings SuggestMarch 3, 2025 | finance.yahoo.comVeracyte, Inc. (NASDAQ:VCYT) Position Reduced by Fisher Asset Management LLCFisher Asset Management LLC cut its position in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 3.7% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 845,718 shares of the biotechnology company's stMarch 3, 2025 | marketbeat.comDecoding Veracyte Inc (VCYT): A Strategic SWOT InsightMarch 1, 2025 | gurufocus.comY Intercept Hong Kong Ltd Purchases New Position in Veracyte, Inc. (NASDAQ:VCYT)Y Intercept Hong Kong Ltd purchased a new stake in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased 21,361 shares of the biotechnology company's stock, vaFebruary 28, 2025 | marketbeat.comVeracyte (NASDAQ:VCYT) Rating Lowered to "Hold" at StockNews.comStockNews.com downgraded shares of Veracyte from a "buy" rating to a "hold" rating in a research note on Wednesday.February 28, 2025 | marketbeat.comPhocas Financial Corp. Decreases Stake in Veracyte, Inc. (NASDAQ:VCYT)Phocas Financial Corp. lowered its position in Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 84.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 7,906 shares of the biotechnology company's stock after selling 44,613February 27, 2025 | marketbeat.comIeq Capital LLC Takes Position in Veracyte, Inc. (NASDAQ:VCYT)Ieq Capital LLC purchased a new stake in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 14,657 shares of the biotechnology company's stock, valued at approximately $580,000. SeveralFebruary 27, 2025 | marketbeat.comVeracyte (NASDAQ:VCYT) Trading Up 9.9% on Analyst UpgradeVeracyte (NASDAQ:VCYT) Shares Up 9.9% Following Analyst UpgradeFebruary 26, 2025 | marketbeat.comGuggenheim Remains a Buy on Veracyte (VCYT)February 26, 2025 | markets.businessinsider.com Remove Ads Get Veracyte News Delivered to You Automatically Sign up to receive the latest news and ratings for VCYT and its competitors with MarketBeat's FREE daily newsletter. Email Address VCYT Media Mentions By Week VCYT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VCYT News Sentiment▼0.900.53▲Average Medical News Sentiment VCYT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VCYT Articles This Week▼126▲VCYT Articles Average Week Remove Ads Get Veracyte News Delivered to You Automatically Sign up to receive the latest news and ratings for VCYT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Hims & Hers Health News Today Option Care Health News Today Guardant Health News Today RadNet News Today Sotera Health News Today BrightSpring Health Services News Today Surgery Partners News Today Concentra Group Holdings Parent News Today Privia Health Group News Today LifeStance Health Group News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VCYT) was last updated on 4/3/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredBrace Yourself for Jeff Bezos’ “Amazon Helios”Jeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Veracyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Veracyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VCYT Stock Free VCYT Stock Alerts